Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WARTS-2
NL-OMON25205Not yet recruiting
- Sponsor
- Prof. dr.WJJ Assendelft, head of department Public Health and Primary Care Leiden University Medical Centre
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of monochloroacetic acid and Salvax in common wart, plantar wart and verruca (4 arms), sponsored by Prof. dr.WJJ Assendelft, head of department Public Health and Primary Care Leiden University Medical Centre. Primary endpoint: Cure at 13 weeks. Planned start Sep 2009; status: not yet recruiting.
02
Drugs
monochloroacetic acidSalvax
03
Conditions
common wartplantar wartverruca
Beyond the preview
Go deeper on NL-OMON25205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25205.